Ulcerative Colitis (UC) and Crohn’s Disease (CD) are chronic inflammatory bowel diseases that affect the digestive tract. Both conditions can lead to ongoing symptoms like diarrhea, abdominal pain, rectal bleeding, and inflammation in the gut. These symptoms can significantly disrupt daily life and overall well-being.
A clinical trial is being conducted to evaluate how many participants with UC and CD experience relief from their symptoms after an investigational treatment. The goal is to see how effectively the treatment helps patients achieve remission—meaning their signs and symptoms go away. This research may offer new hope for those struggling with the daily challenges of these conditions.
